LeonaBio IncLONA
Price$4.38

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Margins

Current

Quality Metrics

Earnings-Beat Rate25.0%

Dividend

No dividend

Segment Performance

SegmentRevenueYoYOutlook
Developing and commercializing therapeutics$0
View details

Focusing on the clinical development of lead drug candidates lasofoxifene (Phase 3 ELAINE-3 trial) and ATH-1105 (Phase 2 ALS trial).

All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.